Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4278864 | The American Journal of Surgery | 2013 | 6 Pages |
BackgroundPrognosis in peritoneal carcinomatosis from gastric cancer has improved with cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy. The aim of this study was to identify predictive factors for incomplete CS.MethodsForty-five patients undergoing laparotomy for gastric cancer with peritoneal carcinomatosis were prospectively included from January 2000 to December 2010. In case of optimal CS, patients (n = 14) received hyperthermic intraperitoneal chemotherapy. Otherwise, the laparotomy was closed or a palliative procedure was performed if necessary. All preoperative data were compared between the 2 groups.ResultsAscites (hazard ratio, .09; 95% confidence interval, .010–.48; P = .0103) and nutritional status evaluated by the prognostic nutrition index (hazard ratio, .11; 95% confidence interval, .0019–.54; P = .027) were independent predictive factors for incomplete CS.ConclusionsThe selection of patients for CS plus hyperthermic intraperitoneal chemotherapy should include the assessment of nutritional status and the detection of an ascites.